Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$21.54 - $24.41 $29 Million - $32.9 Million
-1,346,312 Reduced 20.7%
5,157,370 $117 Million
Q2 2023

Jul 31, 2023

BUY
$12.62 - $24.47 $8.8 Million - $17.1 Million
697,044 Added 12.0%
6,503,682 $159 Million
Q1 2023

May 08, 2023

BUY
$12.98 - $17.1 $2.86 Million - $3.77 Million
220,693 Added 3.95%
5,806,638 $78.2 Million
Q4 2022

Feb 13, 2023

BUY
$13.92 - $17.0 $23.2 Million - $28.3 Million
1,667,595 Added 42.56%
5,585,945 $86.9 Million
Q3 2022

Nov 14, 2022

BUY
$13.36 - $16.75 $8.4 Million - $10.5 Million
628,381 Added 19.1%
3,918,350 $58.7 Million
Q2 2022

Nov 14, 2022

BUY
$12.69 - $19.25 $3.39 Million - $5.14 Million
266,811 Added 8.83%
3,289,969 $47.6 Million
Q2 2022

Sep 13, 2022

BUY
$12.69 - $19.25 $62,828 - $95,306
4,951 Added 0.16%
3,168,283 $45.8 Million
Q2 2022

Aug 02, 2022

BUY
$12.69 - $19.25 $3.14 Million - $4.76 Million
247,074 Added 8.47%
3,163,332 $45.9 Million
Q1 2022

Nov 14, 2022

SELL
$15.5 - $23.89 $2.25 Million - $3.47 Million
-145,125 Reduced 4.58%
3,023,158 $55.3 Million
Q1 2022

Sep 13, 2022

BUY
$15.5 - $23.89 $28,814 - $44,411
1,859 Added 0.06%
2,916,258 $53.3 Million
Q1 2022

May 09, 2022

BUY
$15.5 - $23.89 $8.65 Million - $13.3 Million
558,299 Added 23.7%
2,914,399 $53.4 Million
Q4 2021

Jan 27, 2022

BUY
$20.04 - $23.84 $8.27 Million - $9.84 Million
412,554 Added 21.23%
2,356,100 $55.5 Million
Q3 2021

Nov 12, 2021

BUY
$17.38 - $21.54 $3.96 Million - $4.91 Million
228,007 Added 13.29%
1,943,546 $39.4 Million
Q2 2021

Jul 29, 2021

BUY
$18.47 - $22.11 $2.6 Million - $3.11 Million
140,850 Added 8.94%
1,715,539 $32.7 Million
Q1 2021

May 14, 2021

BUY
$19.22 - $24.3 $5.71 Million - $7.22 Million
297,320 Added 23.28%
1,574,689 $30.3 Million
Q4 2020

Feb 12, 2021

BUY
$18.2 - $22.45 $23.2 Million - $28.7 Million
1,277,369 New
1,277,369 $27.5 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.